NeuroZone
Europe, Lombardia, Italy, Milan
Description
unctional service company supporting drug discovery and research projects in the fields of inflammation and age-related pathologies
Investor Profile
NeuroZone has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A rounds (top funding stages).
- Majority of deals are located in Italy.
- Strong thematic focus on Biotechnology, Health Diagnostics, Life Science.
Stage Focus
- Series B (50%)
- Series A (50%)
Country Focus
- Italy (100%)
Industry Focus
- Biotechnology
- Health Diagnostics
- Life Science
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
